KL (Klotho) is an aging-suppressor gene that encodes a single-pass transmembrane protein functioning as an essential co-receptor for fibroblast growth factor 23 (FGF23) and exerts multiple protective effects on the nervous system. Klotho deficiency accelerates aging phenotypes, while its overexpression extends lifespan.
| Klotho Protein |
|---|
| Gene | [KL](/genes/kl) |
| UniProt ID | [Q9UEF5](https://www.uniprot.org/uniprotkb/Q9UEF5) |
| PDB Structures | 5K2V, 5W5V, 6A6P |
| Molecular Weight | ~130 kDa (membrane form) |
| Subcellular Localization | Cell membrane, extracellular |
| Protein Family | Klotho family |
Klotho exists in multiple forms:
- Membrane-bound Klotho: Type I transmembrane protein with extracellular KL1 and KL2 domains
- Soluble Klotho (sKlotho): Shedded extracellular domain with endocrine functions
- KL1 domain: Contains FGF23 co-receptor activity
- KL2 domain: Required for beta-glucuronidase activity
In the nervous system, Klotho exhibits protective functions:
- FGF23 Co-receptor: Enables FGF23 signaling for phosphate and vitamin D metabolism
- Oxidative Stress Protection: Activates Nrf2 pathway and enhances antioxidant defenses
- Calcium Homeostasis: Regulates calcium channels and neuronal excitability
- Synaptic Function: Preserves synaptic plasticity and memory
- Myelin Maintenance: Supports oligodendrocyte maturation and myelination
- Autophagy Enhancement: Promotes cellular clearance mechanisms
Klotho is expressed in the choroid plexus, hippocampus, cortex, and substantia nigra.
- Cognitive protection: Higher Klotho levels correlate with better cognitive performance
- Amyloid interaction: Klotho enhances amyloid clearance via the choroid plexus
- Tau pathology: Reduces tau phosphorylation and aggregation
- Therapeutic potential: Soluble Klotho as a biomarker and therapeutic agent
- Dopaminergic protection: Klotho protects substantia nigra neurons from degeneration
- Alpha-synuclein: Modulates alpha-synuclein aggregation and toxicity
- Mitochondrial function: Enhances mitochondrial quality control
¶ Aging and Cognitive Decline
- Longevity factor: Klotho is the first aging gene linked to extended human lifespan
- Cognitive enhancement: Overexpression improves memory and synaptic function
- Vascular protection: Maintains blood-brain barrier integrity
- ALS: Altered Klotho expression in motor neurons
- Multiple Sclerosis: Reduced Klotho in demyelinating disease
- Stroke: Protective effects against ischemic damage
Klotho-based therapeutic approaches:
| Agent |
Mechanism |
Development Stage |
| Recombinant sKlotho |
Protein replacement |
Preclinical |
| Gene therapy |
Viral Klotho delivery |
Research |
| Small molecule activators |
Upregulate endogenous Klotho |
Drug screening |
| FGF23 modulators |
Indirect Klotho activation |
Investigational |
- Kuro-o et al., Klotho as a regulator of aging (1997)
- Koyama et al., Klotho and neurodegeneration (2020)
- Zeldich et al., Klotho neuroprotective mechanisms (2014)
- Chen et al., Soluble Klotho in AD (2018)
- Leon et al., Klotho and alpha-synuclein (2021)